He qualified in medicine at Cambridge and Oxford Universities, and general medical training in London, specialising in neurology. He was awarded a PhD from Cambridge University.
His area of research is in advanced clinical trial design in progressive MS. He is the lead researcher for the MS-STAT2 trial.
Dr Chataway is registered with the General Medical Council